# Review

Gemini was intentionally not called because the active user goal says to ignore Gemini.

## Claude Wrapper

Claude wrapper analysis/review was attempted three times:

- analysis session `10f7864f-4712-4198-84f8-9d1a76509677`
- retry analysis session `9e93e955-d0a3-45d3-bc31-be9cb8368c40`
- review session `5ac6507b-6b49-46eb-b5b0-a5d7dbd4b148`

All three wrapper calls exited with status 1 before returning useful analysis or review content. Work continued from local Rust source evidence and test results.

## Read-Only CCG Review

Review agent: `/root/review_complete_fda_probe_set`

Result:

- No Critical or Warning issues.
- Info: implementation rejected `/Users/.` and `/Users/..`, but direct tests only covered `/Users/..`.

Action:

- Added `/Users/.` regression coverage to CLI and frontend tests.

Final review agent: `/root/review_complete_fda_probe_set_final`

Result:

- No Critical or Warning issues.
- Info about missing `/Users/.` coverage was addressed before final verification.

## Verification

- `npm test -- fda-evidence-validator smoke macos-permission-release-evidence-validator` passed: 3 files, 40 tests.
- `npm test` passed: 31 files, 315 tests.
- `npm run lint` passed.
- `git diff --check` passed.

## Result

Approved. FDA evidence validators now require the complete Rust default TCC probe set, same-user user probe paths, no duplicates/extras, and no traversal-shaped user path segments.
